Improving Treatment Adherence in Your Patients with Schizophrenia
Fernando Cañas(Friedrich-Alexander-Universität Erlangen-Nürnberg), Miquel Roca(Instituto de Salud Carlos III), Georgios Papageorgiou(Evangelismos Hospital), Vincent Dubois(Cliniques Universitaires Saint-Luc), Köksal Alptekın(Dokuz Eylül University), Philip Gorwood(Inserm), Peter Haddad(Deakin University), J.M. Olivares, Antonio G. Garcı́a(Universidad Complutense de Madrid), Dieter Naber(Universität Hamburg), J.-M. Azorin(Hôpital Sainte-Marguerite), Robin Emsley(Stellenbosch University)
Cited by 49
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k